To investigate the clinical significance of mutation in hepatitis B virus (HBV) surface gene, DNA sequence analysis of the ''a'' determinant was performed on sera from 27 carrier children with immunoprophylaxis, their mothers, and 21 carriers without vaccination. A precore mutant (G to A) at nucleotide 1896 was detected in sera from 11 carriers without vaccination. Mutations in the ''a'' determinant were detected in 6 (22%) of the vaccinated children. Four HBV strains showed a Gly-to-Arg mutation at the 145th codon of the surface gene. Amino acid substitutions at amino acid 133 and 144 were noted in the other 2 children. Only 1 mother had the same predominant strain of mutant virus as her child. These observations indicate that immune pressure exerted by immunoprophylaxis at birth may select for a mutant virus.
Infants born to hepatitis B e antigen (HBeAg) -positive carSome mutations in the ''a'' determinant of HBsAg were noted in carriers that failed to be protected by immunoprophyrier mothers are prone to contract hepatitis B virus (HBV) infection at birth, and Ç90% of them will become carriers [1] .
laxis [8 -15] . It was suggested that such mutants escape from the immune pressure and may become dominant strains after Although these high-risk infants may be protected from HBV infection by administration of hepatitis B immune globulin universal vaccination. However, these investigations did not use carriers without vaccination as a comparison group. It is (HBIG) and hepatitis B vaccine soon after birth, there is still a carrier rate of 5% -10% [2 -4] .
not known whether the presence of HBV mutant in vaccinees simply reflects the prevalence of HBV mutant in a specific The cause of immunization failure is unclear. Available evidence at present indicates several possible mechanisms, such geographic area or is indeed due to the immune pressure induced by vaccination. In addition, HBV strains in the mother as a high virus load from the mother [5] , intrauterine infections [6] , and a genetic hyporesponsiveness to the vaccine antigen at delivery must be characterized to clarify whether there is a selection process after the birth of carrier children. [7] . Recently, some cases of vaccine failure were attributed to HBV strains with surface gene mutations; these strains may To delineate the prevalence and the type of HBV mutant in vaccinated carrier children in Taiwan and to clarify whether escape neutralization by HBIG and antibodies elicited by vaccination [8 -15] .
vaccination is associated with an immune selection of HBV Although there are several subtypes of HBV, all share the mutant, DNA sequence analysis of the gene encoding the ''a'' 24-aa neutralization epitope (the common ''a'' determinant) determinant was conducted on sera from 27 vaccinated carrier within the hepatitis B surface antigen (HBsAg). The common children, their mothers at delivery, and 21 unvaccinated carriers. ''a'' determinant lies between aa 124 and 147 of HBsAg [16] and is believed to have a double-loop conformation [17] . Antibodies to this antigenic epitope confer protection against all Subjects and Methods subtypes of HBV [18] . Mutations in this region may lead to a substantial change of antigenicity and a reduced cross-reactivCarriers after vaccination. Trials of hepatitis B vaccine had been conducted on 455 infants born to HBeAg-positive mothers ity with polyclonal hepatitis B surface antibody (anti-HBs) from 1988 to 1992 [3, 4, 21] . All of these infants received 0.5 mL [9, 19, 20] . the follow-up period. Among the remaining 5 children, serum children. This may also be exemplified by the sequencing results of patient 3, who had wild type HBV at 6 months of age at birth was negative by PCR in 3 of them and was insufficient for PCR in 2 of them. All sera taken after 6 months of age and mutant HBV after 12 months of age. Relatively high antiHBs concentrations in patients 1 and 4 also implied that vacwere positive by PCR. Mutant viruses appeared at 6 months of age in 4 children (patients 1, 2, 4, 5). In patient 3, the cine-induced antibodies could not neutralize mutant HBV. HBV has a higher intrinsic mutation rate than other DNA predominant HBV strain was wild type at 6 months of age and shifted to a mutant virus after 12 months of age. All mutant viruses, probably because its replication requires an intermediate RNA molecule and reverse transcriptase [23] . Although the viruses were stably present during the follow-up period.
Sequencing results in mothers and unvaccinated carriers. mutant may arise de novo after vaccination, there is evidence suggesting that mutants may be selected from a quasispecies Only 1 mother had the same mutant virus as her child (patient 6). DNA sequences of the ''a'' determinant in the remaining of HBV by immune pressure. By sequencing surface gene clones, Okamoto et al. [12] demonstrated that wild type and 26 mothers were wild type. Whether having a mutation in the precore gene or not, all virus strains in 21 unvaccinated carriers mutant HBV coexisted in a mother who gave birth to 2 children infected by mutant HBV. showed wild type sequence in the ''a'' determinant.
None of the HBV strains in 21 carriers without vaccination had an altered ''a'' determinant. Taking together the sequencDiscussion ing results of 27 mothers, only 1 mutation of the ''a'' determinant was noted in 48 carriers without vaccination in Taiwan. There have been a total of 31 missense mutations in the ''a'' Therefore, the appearance of the HBV mutant is not simply determinant from 27 carriers who failed to be protected by due to a geographic prevalence of mutant virus but is indeed HBIG or hepatitis B vaccine (or both) [8, 11 -15] . The present due to the immune pressure induced by active-passive immunistudy adds 8 mutations from 6 carriers to these data (figure 1).
zation. Consistent with previous reports, the Gly-to-Arg mutation at A precore mutant (G to A) at nucleotide 1896, resulting in aa 145 is the most commonly found mutation. Two mutations a stop codon, has been noted in many patients with acute or in the present study have not been reported previously: the chronic HBV infection [24 -27] . Although it is still debated substitutions from Ser to Tyr at aa 132 (patient 3) and from whether this is a preceding event or a consequence, this mutaPhe to Leu at aa 134 (patient 4). However, these mutations tion was related to the occurrence of HBeAg clearance [24, occurred concurrently with the Gly-to-Arg mutation at aa 145 25] and fulminant hepatitis [26, 27] . In the present study, 11 and may therefore be of minor significance.
HBV strains from 21 carriers without vaccination showed such Among the 6 carrier children with mutant HBV, only 1 of a precore mutation. However, none of them showed a mutation their mothers had the same mutant virus at delivery. Taking in the ''a'' determinant of the surface gene. This observation together our study results, the ''a'' determinant has been charillustrated two different types of immune selection. To establish acterized in 12 mothers who gave birth to children with mutant an infection, altered epitopes in the surface protein may facili-HBV infection [8, 11, 12, 14, 15] . Only 2 mothers possessed tate HBV to escape from immune pressure against the surface the same dominant strain of mutant HBV as found in the child, antigen. In patients with chronic hepatitis and fulminant hepatiincluding patient 6 in present study. This finding indicates that tis, mutations in the precore gene may facilitate HBV to escape immune selection does occur after the birth of these carrier from immune pressure against the core antigen. This finding is consistent with our current understandings of HBV immunology; that is, the immune response against surface antigen may protect from infection, and the primary immune target in an established hepatic infection is the core antigen. A large-scale screening for HBV mutants in vaccinated carriers has also been done in Singapore [14] . Eighteen (42%) of 43 carrier children with sequencing results showed some mutations in the ''a'' determinant. This rate of mutation after vaccination is higher than that of the present study (6/27, 22%), indicating that there may be some geographic differences in the prevalence of the HBV mutant.
With universal vaccination, it is of concern that HBV surface observed in carriers without vaccination [28, 29] . Incorporation teine molecules (C) [8] . Numbers beside solid circles represent number of mutations observed in each corresponding amino acid.
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